The Iphone Effect In Healthcare: How Mounjaro Is Rewriting The Economics Of India's Pharma Market
(MENAFN- Live Mint) Mumbai: For years, GlaxoSmithKline's Augmentin, a broad-spectrum antibiotic, held a place at the top of India's pharmaceutical sales charts. Its reign reflected the economics of a market built on scale, volume and affordable medicines. That pecking order has now been overturned by GLP-1 drugs, sought after for weight-loss and diabetes treatment. Eli Lilly's patented Mounjaro has emerged as the country's top-selling drug by sales.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment